Cleo Diagnostics (ASX:COV) Days Sales Outstanding : 0.00 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Cleo Diagnostics Days Sales Outstanding?

Cleo Diagnostics's average Accounts Receivable for the six months ended in Dec. 2023 was A$0.10 Mil. Cleo Diagnostics's Revenue for the six months ended in Dec. 2023 was A$0.00 Mil.

The historical rank and industry rank for Cleo Diagnostics's Days Sales Outstanding or its related term are showing as below:

ASX:COV's Days Sales Outstanding is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 64.77
* Ranked among companies with meaningful Days Sales Outstanding only.

Cleo Diagnostics's Days Sales Outstanding stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).

Cleo Diagnostics Days Sales Outstanding Historical Data

The historical data trend for Cleo Diagnostics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleo Diagnostics Days Sales Outstanding Chart

Cleo Diagnostics Annual Data

Trend

Jun23

Days Sales Outstanding

Cleo Diagnostics Semi-Annual Data
	Dec22	Jun23	Dec23
Days Sales Outstanding	-	-	-

Competitive Comparison of Cleo Diagnostics's Days Sales Outstanding

For the Medical Devices subindustry, Cleo Diagnostics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cleo Diagnostics's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cleo Diagnostics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Cleo Diagnostics's Days Sales Outstanding falls into.

Cleo Diagnostics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Cleo Diagnostics's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: . 20 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (	+	0.032)	/	1 )	/	0	*	365
=	0.032					/	0	*	365
=	N/A

Cleo Diagnostics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.032	+	0.162)	/	2 )	/	0	*	365 / 2
=	0.097					/	0	*	365 / 2
=	N/A

Cleo Diagnostics (ASX:COV) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Cleo Diagnostics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Cleo Diagnostics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Cleo Diagnostics (ASX:COV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cleo Diagnostics Ltd (ASX:COV) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

480 Collins Street, Level 2, Melbourne, VIC, AUS, 3000

Website

https://www.cleodx.com

Cleo Diagnostics Ltd is focused on the development of non-invasive blood-based IVD tests to detect the presence, and recurrence, of ovarian cancer. The Company's first product to market is intended to be the Triage Test which has to date produced strong results to accurately differentiate patients with malignant ovarian cancer from those with benign gynaecological conditions. The Company aims to improve the diagnostic process and procedures for detecting ovarian cancer and, in this regard, improve quality-of-life outcomes for patients who have been diagnosed with ovarian cancer.

Cleo Diagnostics (ASX:COV) Headlines

No Headlines